Researchers reviewed data from eight observational studies involving 69,819 patients to see if catheter ablation for atrial fibrillation works differently in people with a history of cancer. They compared outcomes between patients with cancer and those without cancer. Catheter ablation is a procedure that uses heat or cold to create small scars in the heart to block irregular electrical signals.
The main finding was that most outcomes were similar between the two groups. There was no significant difference in how often atrial fibrillation returned, whether patients needed a repeat procedure, or in mortality rates. However, the analysis showed a trend toward more clinically relevant bleeding within three months after the procedure in cancer patients (4.9% vs. 3.3%), though this difference did not reach statistical significance.
It's important to be careful with these results because they come only from observational studies, not randomized controlled trials. Observational studies can show associations but cannot prove cause and effect. The researchers noted that no randomized trials on this topic were available to include. This means the evidence is less certain than if it came from more rigorous study designs. Patients should discuss their individual risks and benefits with their healthcare team.
